EPHB4 and prostate carcinoma: EPHB4 knockdown in human (PC-3, 22Rv1 and LNCaP) and mouse (Myc-CaP & Myc-CaP; Pten KO) prostate cancer cell lines resulted in a decrease in cell viability measured after 72 h (Fig. 2b).